Acción NUTRIBAND INC
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Nutriband Inc Other OTC

Acciones

US67092M1099

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
Nutriband Inc. Provides Product Development Update for its Lead Product Aversa Fentanyl
Nutriband Inc.
Treatment.com AI's (CSE: TRUE) Strategic Partnership with Novus Health, New Board Appointment, and Major Contract To Revolutionize Healthcare, Driving Momentum in the Industry
Nutriband Inc. Reports Earnings Results for the First Quarter Ended April 30, 2024
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
Nutriband Inc. Appoints Sergei Glinka to Its Board of Directors
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
Tranche Update on Nutriband Inc.'s Equity Buyback Plan announced on December 30, 2021.
Nutriband Inc. Reports Earnings Results for the Full Year Ended January 31, 2024
Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch through FDA Submission
IBN Coverage Initiated for Nutriband Inc.
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
Nutriband Inc. Closes $8.4 Million Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
Nutriband Inc. announced that it expects to receive $8.4 million in funding
Nutriband Inc. Announces $8.4M Private Placement
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
Nutriband Inc. Receives First Order from Fit for Life Group
Nutriband Inc. Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
Nutriband Inc. Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented At 2024 American Academy of Pain Medicine Annual Meeting
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción NTRB
  4. Acción
  5. Noticias Nutriband Inc
  6. Otros idiomas